全文获取类型
收费全文 | 422470篇 |
免费 | 45689篇 |
国内免费 | 3688篇 |
专业分类
耳鼻咽喉 | 8470篇 |
儿科学 | 13637篇 |
妇产科学 | 8289篇 |
基础医学 | 41388篇 |
口腔科学 | 7507篇 |
临床医学 | 48348篇 |
内科学 | 107889篇 |
皮肤病学 | 14036篇 |
神经病学 | 38795篇 |
特种医学 | 14860篇 |
外国民族医学 | 103篇 |
外科学 | 74976篇 |
综合类 | 3282篇 |
现状与发展 | 73篇 |
一般理论 | 64篇 |
预防医学 | 30258篇 |
眼科学 | 8415篇 |
药学 | 20980篇 |
8篇 | |
中国医学 | 1647篇 |
肿瘤学 | 28822篇 |
出版年
2023年 | 6199篇 |
2022年 | 2972篇 |
2021年 | 7907篇 |
2020年 | 8766篇 |
2019年 | 6997篇 |
2018年 | 15659篇 |
2017年 | 12871篇 |
2016年 | 13950篇 |
2015年 | 14812篇 |
2014年 | 22479篇 |
2013年 | 26474篇 |
2012年 | 23942篇 |
2011年 | 23979篇 |
2010年 | 19638篇 |
2009年 | 21376篇 |
2008年 | 21641篇 |
2007年 | 20926篇 |
2006年 | 22014篇 |
2005年 | 19078篇 |
2004年 | 17380篇 |
2003年 | 14989篇 |
2002年 | 14304篇 |
2001年 | 11236篇 |
2000年 | 10474篇 |
1999年 | 9897篇 |
1998年 | 4963篇 |
1997年 | 4512篇 |
1996年 | 4394篇 |
1995年 | 4090篇 |
1994年 | 2737篇 |
1993年 | 2245篇 |
1992年 | 5201篇 |
1991年 | 4804篇 |
1990年 | 4299篇 |
1989年 | 4196篇 |
1988年 | 3814篇 |
1987年 | 3454篇 |
1986年 | 3351篇 |
1985年 | 2902篇 |
1984年 | 2193篇 |
1983年 | 1910篇 |
1982年 | 1288篇 |
1979年 | 1718篇 |
1978年 | 1298篇 |
1977年 | 1295篇 |
1974年 | 1325篇 |
1973年 | 1345篇 |
1972年 | 1359篇 |
1971年 | 1231篇 |
1970年 | 1206篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo oligometastases, and oligoprogressive disease likely have unique biologic underpinnings and natural histories. Evidence suggesting the existence of a subset of patients who harbor prostate cancer with limited metastatic potential currently includes disparate and overwhelmingly retrospective reports. Nevertheless, emerging prospective data have corroborated the “better-than-expected,” retrospectively observed outcomes, particularly in the setting of oligorecurrent prostate cancer. Improved functional imaging with prostate-specific membrane antigen-targeted strategies may enhance the identification of patients with oligometastatic prostate cancer in the short term. In the long term, refinement of the oligometastatic case definition likely will require biologic risk-stratification schemes. To determine optimal treatment strategies and identify patients most likely to benefit from metastasis-directed therapy, future efforts should focus on conducting high-quality, prospective trials with much-needed molecular correlative studies. 相似文献
102.
103.
104.
105.
106.
Estefany I. Medina-Reyes Carolina Rodríguez-Ibarra Daniel Díaz-Urbina Alejandro Déciga-Alcaraz Normal L. Delgado-Buenrostro Yolanda I. Chirino José Pedraza-Chaverri 《Journal of applied toxicology : JAT》2022,42(8):1411-1419
Food-grade titanium dioxide (E171) is widely used as a food additive, and it is known that after oral consumption, E171 is translocated into the bloodstream reaching the highest titanium level at 6 h. E171 is accumulated in some organs triggering toxicity, but the effects on the blood parameters after oral consumption have been less studied. Recently, evidence shows that oral exposure to E171 induces behavioral signs of anxiety and depression. The relation between blood alterations and psychiatric disorders has been previously demonstrated. However, the oral exposure to E171 effects on alterations in blood parameters and effects linked to alterations in animal behavior has not been explored. In this short communication, we aimed to investigate the effects of E171 on specific blood parameters (hematocrit, hemoglobin, number of erythrocytes, and leukocytes) and anxiety and compulsive-like behavior in males and females orally exposed to ~5 mg/kg for 4 weeks. The results showed that E171 decreased hematocrit and hemoglobin in male but not in female mice while leukocyte and erythrocyte count remained unaltered. Oral consumption of E171 decreased the levels of anxiety-like behavior in females but not in male mice, while compulsive-like behavior was increased in both male and female mice. 相似文献
107.
108.
109.
110.
A. Cattapan K. Browne D.M. Halperin A. Di Castri P. Fullsack J. Graham J.M. Langley B.A. Taylor S.A. McNeil S.A. Halperin 《Vaccine》2019,37(2):289-295